key: cord-0960586-0z63g1ik
authors: Ahmadi, Sepideh; Rabiee, Navid; Fatahi, Yousef; Hooshmand, Seyyed Emad; Bagherzadeh, Mojtaba; Rabiee, Mohammad; Jajarmi, Vahid; Dinarvand, Rassoul; Habibzadeh, Sajjad; Saeb, Mohammad Reza; Varma, Rajender S.; Shokouhimehr, Mohammadreza; Hamblin, Michael R.
title: Green Chemistry and Coronavirus
date: 2021-03-03
journal: Sustain Chem Pharm
DOI: 10.1016/j.scp.2021.100415
sha: 4fdcddb2ae3137603693dc7637477a22f21b0671
doc_id: 960586
cord_uid: 0z63g1ik

The novel coronavirus pandemic has rapidly spread around the world since December 2019. Various techniques have been applied in identification of SARS-CoV-2 or COVID-19 infection including computed tomography imaging, whole genome sequencing, and molecular methods such as reverse transcription polymerase chain reaction (RT-PCR). This review article discusses the diagnostic methods currently being deployed for SARS-CoV-2 identification including optical biosensors and point-of-care diagnostics that are on the horizon. These innovative technologies may provide a more accurate, sensitive and rapid diagnosis of SARS-CoV-2 to manage the present novel coronavirus outbreak, and could be beneficial in preventing any future epidemics. Furthermore, the use of green synthesized nanomaterials in the optical biosensor devices could leads to sustainable and environmentally-friendly approaches for this crisis.

The sudden appearance of the novel coronavirus (SARS-CoV-2) in Wuhan, China, in December 2019, was the third type of coronavirus to cause serious infections in humans. It has had unprecedented adverse effects, not only on the healthcare services, but also on the world economy (Udugama et al., 2020) . Earlier, acute respiratory syndrome coronavirus (SARS-CoV) was identified in Asia in 2003, and an outbreak of Middle East Respiratory Syndrome (MERS-CoV) in Saudi Arabia in 2012 (Wang and Anderson, 2019; Ksiazek et al., 2003) . Until now, despite the decline in the newly diagnosed patients in many countries, the World Health Organization (WHO) has warned that the spread of the SARS-COV-2 still has "growth potential". As of 1 st Sep.2020, more than 60 million people have been infected with COVID-19 worldwide with more than more than 1·4 million deaths as of November, 2020 (Bhaskaran et al., 2021) . Therefore, it is necessary to expeditiously develop new accurate J o u r n a l P r e -p r o o f diagnostic methods with high sensitivity to reduce the mortality rate .

Lung computed tomography (CT) is used as an initial diagnostic procedure in individuals with suspected SARS-CoV-2, however, this technique can solely make possible to assess the patient's lungs, but cannot easily be applied to monitor the results of therapy (Ai et al., 2020; Çinkooğlu et al., 2020) . Molecular techniques such as reverse transcription polymerase chain reaction (RT-PCR) are employed to detect the genetic material of the virus in patients with symptoms of active infection. PCR testing can confirm the diagnosis of coronavirus when two specific SARS-CoV-2 genes have been identified. If only one of these genes is detected, the diagnosis is uncertain Corman et al., 2020) . PCR tests may produce false-negative results that fail to identify the presence of SARS-COV-2 (Wikramaratna et al., 2020) , which may be due to human error or problems with the test procedure itself.

In order to protect vulnerable individuals, it is essential to rapidly establish the infection status of patients with SARS-COV-2, as well as for the hospital and emergency personnel.

The current RT-PCR test requires several steps and needs several hours for sampling and the evaluation (Wikramaratna et al., 2020) . On the other hand, the need for patients to attend hospitals and clinics to provide samples, itself increases the risk of contracting the SARS-COV-2. Therefore, more research is needed to improve diagnostic methods to reduce the mortality by providing more accurate and faster point-of-care (POC) diagnosis, and which could be produced on a commercial scale. So far, several rapid POC tests have been commercialized or developed to diagnose SARS-CoV-2 (Vashist, 2020; Lassaunière et al., 2020) . Evaluation of an antibody IgG/IgM-based POC rapid test showed only low sensitivity (36.4%) (Döhla et al., 2020) . Therefore, due to the need for higher sensitivity and a rapid diagnosis, antigen-based systems or optical nanosensors could be deployed as a fast and safe method for detection of SARS-CoV-2.

Optical biosensors can be categorized into different types, such as surface plasmon resonance (SPR), surface enhanced Raman spectroscopy (SERS), or chemiluminescence (Pirzada and Altintas, 2020) . LSPR and SERS-based optical biosensors are suggested for POC detection systems due to their high diagnostic sensitivity and ability to be commercialized Granger et al., 2016) .

Metallic Nanoparticles (NPs) are widely applied in biomedical filed because of the large surface of them that lets the guest molecules such as drug to absorb, entrap, or bind within the surface of the particles. Metallic NPs, such as Au, Ti, Fe, Se, and Metal Oxide NPs, such as zinc oxide (ZnO), iron oxide (Fe 2 O 3 /Fe 3 O 4 ), titanium oxide (TiO 2 ) etc. have attracted great interests as potential in drug/gene delivery and biosensors due to importance applications in J o u r n a l P r e -p r o o f the sections of clinical and therapy. Green synthesis of metallic and metal oxide NPs using different green reducing agents can provide an eco-friendly condition for biomedical applications especially in the biosensors. Recently, several studies have been done on the green synthesis of metallic and metal oxide NPs with different limit of detection and abilities to transfer the drug/gene to the targeted cell that showed excellent biocompatibility without any toxicity in vitro tests.

Herein this review article, the current serological and molecular techniques for the detection of SARS-CoV-2 are discussed, and the emerging diagnostic systems based on optical biosensors and POC testing are summarized, the techniques discussed being shown in Figure 1 . Furthermore, in this review, a novel approach based on the use of green synthesized nanomaterials for the early diagnosis and detection of SARS-CoV-2 has been discussed indepth. 

Coronavirus are enveloped viruses, belonging to the Coronaviridae family, which are divided into four genera, α, β, γ, and δ; SARS-CoV-2 belongs to the β genus . Transmission electron microscopy (TEM) of human airway epithelial cells J o u r n a l P r e -p r o o f isolated from a coronavirus patient in Wuhan, China, showed that the virus particles were 60 to 140 nm in diameter and had distinctive spikes of 9 to 12 nm (Zhu et al., 2020) . SARS-CoV-2 is a positive sense RNA strand of ~30,000 nucleotides, and contains about 6-11 open reading frames (ORFs) .

ORF 2-10 encode four essential structural proteins, including the nucleocapsid (N), spike (S) glycoprotein, matrix protein, and envelope (E) protein (Ujike and Taguchi, 2015) . The N protein is responsible for packaging the RNA genome, while the E protein enables assembly of the virus, and is important for the pathogenesis. The S protein, for the interaction of the virus with cellular membrane, binds to the angiotensin-converting enzyme 2 (ACE2) receptor on the surface of human cells. Glycoprotein S consists of two subunits, S1 and S2; S1 regulates the tropism of the virus to host cells with its receptor-binding domain (RBD), while S2 facilitates virus-cell membrane fusion via the heptad repeats 1 (HR1) and HR2 domain .

The analysis of the spike protein showed the presence of NH 2 …..S-Cys-G-S-Cys-Cys-K-COOH sequence, with disulfide bonds between cysteine amino-acids (C323, C366, C467, etc.) (Li et al., 2005) . Targeting these disulfide bonds could be an option for designing optical sensors for the detection of SARS-CoV-2.

The subunits of SARS-CoV-2 and SARS-CoV showed 88% similarity in sequence, and their binding to the ACE2 receptor is largely similar (Walls et al., 2020) . However, the RBD domain in the S protein is the most variable part of the viral genome. Some amino-acids in human SARS-CoV-2 (such as, F486, L455, Q493, Y505, etc.) are known to play an important role in binding to ACE2 receptors, as well as in determining the host range of the viruses (Ou et al., 2020; Andersen et al., 2020) . These amino-acids are different between SARS-CoV-2 and SARS-CoV, and also in different virus species that infect specific hosts ( Fig. 2) (Andersen et al., 2020) . Since cross-species diagnosis of the virus could play a significant role in reducing its spread, this feature could be taken into account in the design of specific biosensors.

J o u r n a l P r e -p r o o f nucleic acid and protein sequence of SARS-CoV-2 spike protein (red area), and main residues in the spike protein that bonding to the ACE2 receptor (blue area) (Andersen et al., 2020) .

There is a consensus that it may take between 1-2 weeks from the time the person becomes infected to the onset of symptoms. During this time an individual has the opportunity to infect other people (Qin et al., 2020) . We also need to consider the time required to perform the test and the individual to receive the results. In all countries of the world, testing is important for the early diagnosis of COVID-19 and the immediate isolation of patients diagnosed with the virus, and efforts are being made to develop diagnostic kits and methods with high-sensitivity and specificity. So far, several molecular and serological methods and diagnostic kits have been reported for the detection of COVID-19.

J o u r n a l P r e -p r o o f

After the RNA sequence was determined by whole genome sequencing carried out in China in December 2019, the first diagnostic SARS-CoV-2 kit was developed in Berlin based on RT-PCR which can detect the coronavirus RNA in the first week of infection. This test is based on specific probes and is used only for the detection of RNA of the SARS-CoV-2 virus based on specific genes such as S, E, N and RdRP genes (Corman et al., 2020) . Since viral samples are small and can contain a viral load of only a few particles, false-negative test results and low sensitivity are distinct possibility. The sensitivity of chest CT (98%) was found to be higher than the RT-PCR (71%) in patients at Taizhou Enze Medical Center, China (Fang et al., 2020) .

Following the epidemic of SARS-CoV-2, many companies have developed quantitative real-time PCR (RT-qPCR) detection kits for the clinical diagnosis of virus around the globe.

These experiments were performed based on specific primers for the ORF1ab/RdRp, S, N, and E sequences . Corman et al. developed RT-qPCR assays based on TaqMan fluorescence signal for the detection of the ORF1ab and N regions of the virus with a sensitivity of below 10 copies/reaction in 1 h and 15 min, respectively (Corman et al., 2020) . Up to now, different RT-PCR SARS-CoV-2 testing kits accessible commercially of which 29 kits have been approved by United States Food and Drug Administration (FDA) (Garg et al., 2020) . Kasteren et al. compared seven commercially available RT-PCR testing kits from varius companies and showed ≥ 96% efficiency for the detection of low concentrations of SARS-CoV-2 RNA (Limit of detection (LOD) of 3.8-23 copies/mL) in clinical samples with 100% specificity. They descripted that all seven commercial RT-PCR kits could be used for the routine detection of COVID-19 through diagnostic laboratories (van Kasteren et al., 2020) . The sensitivity and LOD of six approved RT-PCR SARS-CoV-2 testing kits was investigated by Wang et al. High sensitivity and LoDs of 484 copies/ mL was shown for four kits such as Liferiver Biotech, BGI Genomics, SanSure and DAAN and the LoD of BioGerm kit was 968 copies/mL. However, they showed the LOD of 7744 copies/mL for GeneoDx kit that showed lowly sensitivity, which can be attributed to the technical deficiencies in the product's design . An overview of the some available RT-PCR SARS-CoV-2 testing kits and their properties is presented in Table 1. RT-qPCR techniques generally display high specificity and sensitivity in the detection of SARS-CoV, but these approaches are not without limitations. In five patients, whose RT-qPCR test results were negative for SARS-CoV-2, chest CT scans showed positive results J o u r n a l P r e -p r o o f and eventually these 5 patients were found to be infected with the COVID-19 . Other disadvantages of this technique is its time-consuming nature, needs special instruments, high technical operation and a possible long waiting time for results . 

The loop-mediated isothermal amplification (LAMP) technique is a unique nucleic acid amplification method that amplifies reverse-transcribed DNA in a short time, with high specificity under isothermal conditions. In addition, this technique also can be visual, there is no need special instruments, and a constant temperature metal bath is enough. In this method, a DNA polymerase and set of four-six specific primers, amplify target genes up to 10 9 copies (Nagamine et al., 2002; Nguyen et al., 2020) . The LAMP method is more sensitive than conventional PCR technique, and although it is less sensitive compared to qPCR it was faster than the other assays evaluated. In spite of the low sensitivity, the LAMP method showed increased specificity compared to other techniques such as qPCR as a one-step detection method (Khan et al., 2018; . Yan et al. described a reverse transcription LAMP (RT-LAMP) method tested in 130 patients, that was simple, rapid, with specificity and sensitivity of 2×10 1 and 2×10 2 copies/reaction using orf1ab-4 and S-123 primers. The mean time for this method was 26.28 ± 4.48 min, and it could detect the virus in suspicious and high-risk individuals. This method was much faster and simpler than RT-PCR and did not need any complex equipment . Since time and simplicity is crucial in the diagnosis of epidemic diseases, the LAMP technique could be a good option for the POC applications.

POC tests are used to rapidly and accurately diagnose patients without any need to send clinical samples to medical laboratories, and precludes the need for advanced laboratory equipment (Kozel and Burnham-Marusich, 2017) . Nucleic acid extraction, amplification and detection can be combined into one integrated cartridge in POC devices, which will provide rapid, simple, and safe results. LAMP and lateral flow immunoassay (LFIA) could be useful in POC devices to detect COVID-19. The high sensitivity and rapid performance of the LAMP technique makes it a good choice for POC devices (Kozel and Burnham-Marusich, 2017; Vashist, 2020 However, molecular techniques are not without their problems, and require a complicated setup with multiple primers, which might be difficult in some settings, and false positive results can occur due to the use of non-specific dyes (Vijay J. Gadkar et al., 2018) . LFIA is a user-friendly assay format that does not require technical expertise, and can provide a low-cost POC approach for SARS-CoV-2 detection. The lateral flow assay uses a paper or nitrocellulose membrane strip, which is coated with metallic NPs (AuNP)conjugated Antibodies to capture viral proteins in the serum. After adding the patient sample J o u r n a l P r e -p r o o f (blood, plasma, or serum) to the membrane, viral proteins are drawn across the strip. As the virus antigens react with the colloidal gold NPs (AuNPs) -Antibodies in the first line, the complex formed is captured on the strip by IgG and IgM antibody within seconds, and the color of Au NPs change from red to blue because of the plasmon band coupling after aggregation. The results of the test can be read in 10-15 min. Although many companies around the world are developing rapid serological tests, one of the major problems is the cross-reaction between antibodies, which could have a false positive result to other coronaviruses types, and the loss of antibody. As a result, the accuracy of these tests should be determined by further testing (Tomás et al., 2019; Zhao et al., 2020a) .

Researchers are currently studying other diagnostic techniques, including chip-based testing, microfluidics, and nanotechnology-based biosensors for the simple and rapid detection of SARS-CoV-2, as well as developing fully automated in vitro POC diagnosis methods that can perform both molecular and immunological tests on a single analytical platform. Table 2 lists the currently deployed diagnostic techniques with the times, advantages and disadvantages for the detection of SARS-CoV-2. 

The discovery of clustered regularly interspaced short palindromic repeats (CRISPR) was a important step forward in gene editing and diagnostic applications. CRISPR is a type of adaptive immunity applied through bacteria to protect themselves against infection with bacteriophages (Chertow, 2018) . Among different diagnostic techniques, the CRISPR/Cas system is being studied in order to specific and rapid diagnosis of SARS-COV-2.

In recent years, researcher developed a high specific and sensitive detection technology named Specific High-sensitivity Enzymatic Reporter Unlocking (SHERLOCK), which uses the activity of the crRNA/Cas13a protein complex to detection DNA and RNA molecules through amplification of the nucleic acid by an LAMP reaction, then detection of the products using CRISPR mediated reporter unlocking (Joung et al., 2020) . The SHERLOCK system based on CRISPR/Cas13 has been applied to POC detection of SARS-CoV-2 by Zhang et al. who applied two crRNAs that diagnose two gene of COVID-19 such as ORF1ab and S gene in a range 10-100 copies/µL within 1 h . Recently, J o u r n a l P r e -p r o o f researcher showed that the DNA endonuclease-targeted CRISPR trans-reporter (DETECTR), as an inexpensive, visual and fast test could detect SARS-CoV-2 in < 40 min through applying a lateral flow strip depend on a CRISPR system. This assay is based on E, N, and RNase P genes and includes three steps such as LAMP reaction at 62 °C for 30 min, Cas12 detection reaction at 37 °C, which takes 10 min, and RT lateral flow which takes approximately 2 min. The LOD of this assay being 10 copies/µL (Broughton et al., 2020) .

Another study also indicated that a CRISPR/Cas13-based assay could be applied to destroy SARS-CoV-2 sequences in human lung epithelial cells, killing more than 90% of coronavirus (Abbott et al., 2020) .

At present many companies are trying to develop and commercialize POC in vitro diagnostic systems for the early diagnosis and control of COVID-19. The FDA has issued emergency use authorization (EUA) for 20 different SARS-CoV-2 tests, including those from Chembio, Abbott, BioMedomics, etc. A list of some POC devices for COVID-19 that have been, or are in the process of being commercialized, is provided in Table 3 . The first FDA-approved POC system was developed by Cepheid (Cepheid GeneXpert® Systems) for the rapid molecular detection of SARS-CoV-2 which could provide results within 45 minutes and is based on real-time RT-PCR. It is used for qualitative detection of SARS-CoV-2 nucleic acids in a nasopharyngeal swab or nasal wash from individuals suspected of being infected with COVID-19. The system employs disposable cartridges containing the RT-PCR reagents and acting as a platform for the RT-PCR process. The risk of contamination between samples is reduced due to its use of self-contained cartridges. The test costs between $10-$20 per sample (Vashist, 2020; Soon et al., 2013) .

The COVID-19 IgM/IgG Rapid Test system was one of the first rapid POC LIFA systems for the diagnosis of COVID-19 developed by BioMedomics Co., USA, NC. This system is capable of rapid results in 10-15 minutes and is based on IgG and IgM antibodies present in plasma serum and blood samples. Requiring only a very small sample (20 microliters of finger blood or 10 micrograms of serum/plasma), this test may be used anywhere Although the sensitivity of this diagnostic test is 88.66%, tests like LAMP have a higher sensitivity, consequently, this system could be combined with techniques such as LAMP to develop POC systems with greater sensitivity for COVID-19 detection (Sakamoto et al., 2018; Carter et al., 2020) .

The Abbott ID NOW TM test is one of the newest POC tests for COVID-19 detection that can give results within 5 minutes (positive results in 5 minutes and negative ones in 13 minutes). This test is based on the portable NOW platform using isothermal nucleic acid amplification technology and targeting the RdRp Gene. Given its small size, this system may be used anywhere, such as clinics and doctor's offices, with nasal, pharyngeal, or oral samples (Vashist, 2020; Rao et al., 2017) . It is hoped that the development of more rapid J o u r n a l P r e -p r o o f commercial POC systems will help identify the virus and control its spread in many countries.

Although RT-PCR and the chest-CT scan provide highly specific and sensitive detection of COVID-19, they are not suitable for POC devices, due to the need for the expensive equipment, the requirement for travel to the testing centers, and for hospitals to transfer virus contaminated samples.

Nanotechnology is being used in the development of highly-sensitive, accurate, and efficient sensors to eliminate the need for trained staff in identifying viruses and other nanoscale pathogens (20-900 nm). Due to the unique properties of NPs, such as large surface area to volume ratio, and the presence of many reactive sites, nanomaterials can be efficient, more sensitive, and accurate for virus detection. The integration of nanosensors with other diagnostic methods provides more versatile diagnostic systems for the detection of high-risk pathogens both in and out of the laboratory (e.g., POC detection) (Quesada-González and Merkoçi, 2018; Hamdy et al., 2018; Ghasemi et al., 2018) . Consequently, nanosystems have several advantages in the diagnosis of infectious disease. Because early and highly sensitive diagnosis is important in disease prevention and timely treatment, research advances in nanotechnology have been applied to virus detection. Optical biosensors can be used as a simple, safe and rapid method for early detection of epidemic viruses such as COVID-19, and can be deployed using various types of spectrometric readout, such as fluorescence, absorption, or SERS. Among all of these sensors, localized surface plasmon resonance (LSPR) and SERS display real potential as a sensitive optical sensor for virus detection, and have the most promise as POC detection systems, because they are label-free, operate in real time and have high sensitivity (Lee et al., 2017; Tokel et al., 2014) .

In recent years, many groups have investigated the application of biosensors for the accurate and highly-sensitive detection of various biomarkers, and also viruses such as the coronavirus family and influenza virus (Kaya et al., 2020; Nikaeen et al., 2020) . In the following section, some nanosensors that are based on optical signal detection strategies, and their role in the rapid and sensitive detection of the novel coronavirus , are discussed. One point of view suggests that the optimum detection and destruction of nanoscale viruses requires the use of nanoscale materials such as NPs.

J o u r n a l P r e -p r o o f SERS has gained considerable interest as a potential strategy for the diagnosis at a molecular level due to its non-invasive nature, combined with high sensitivity and specificity.

In the SERS technique, after the analyte molecule is absorbed onto a SERS substrate, the Raman signal of the molecule is dramatically increased due to the plasmon resonance at the surface of a gold nanostructure. Unlike fluorescence, which shows broad bands, the spectral band-width of Raman signals are narrow. This high resolution of the peaks in SERS spectra allows simultaneous detection of multiple molecules in the same sample. Other benefits of SERS are its rapid analysis rate, simplicity of sample management, and the ability to produce commercial devices. However, SERS has some limitations, namely the degradation of the Metal organic frameworks (MOF) represent a class of polymers consisting of metal ions or clusters coordinated to organic ligands to produce one, two, or three-dimensional structures.

MOF have been investigated for SERS due to their unique structure and chemical and thermal stability. MOF can serve as solid-phase extraction materials with the ability for rapid concentration and size-selectivity (Lai et al., 2020) . Hundreds to thousands of different MOFs could be included in a library of porous materials for different biological applications (Maurin et al., 2017) . The effects of morphology, size and optical properties of metal NPs such as gold and silver have been explored with the goal of optimizing SERS substrates.

AuNPs (1-200 nm) have been widely applied in the field of virus detection due to their unique optical/electrical properties. Surface plasmon oscillations in AuNPs can increase Raman scattering upon optical excitation (Ou et al., 2019; Qiao et al., 2018) . The examination of gas and liquid phase biomarkers in exhaled breath and coughs could detect respiratory viruses, such as influenza and coronavirus as a non-invasive strategy for rapid diagnosis using the SERS method (Leung et al., 2020) . As shown in Fig. 3A , the self-J o u r n a l P r e -p r o o f assembled AuNPs formed a "gold superparticle" (GSP) structure with approximately 170 nm diameter. In order to increase the adsorption of gaseous or liquid molecules, a ZIF-8 metalorganic-framework layer was coated onto GSPs. These MOFs lowered the electromagnetic field around the GSP surface, and with a reduced gas flow rate, they provided sufficient time for the adsorption of volatile organic compounds (VOCs) that could serve as lung cancer biomarkers onto the SERS substrate. Reactions that formed a Schiff base between the amine groups of Raman-active 4-aminothiophenol (4-ATP) molecules absorbed onto GSPs and the aldehyde groups present in analytes, allowed the detection of aldehyde-containing VOCs at the 10 ppb level (Fig. 3B-C) . This SERS sensor showed the ability to detect cancer biomarker at early stages, and also had the ability to serve as a simple biosensor for early and highly sensitive detection of COVID-19 based on the structure of viral antigens and their interaction with the GSP/ ZIF-8 substrate (Qiao et al., 2018) . There is a great interest in using green synthesized NPs for this purpose, and in this case, by using the sustainable and green synthesized nanomaterials/NPs, the limit of detection of the biosensor could increase substantially. (Qiao et al., 2018) .

In order to overcome some limitations of immunoassay techniques, the combination of an immunoassay with SERS nanotags could provide a stable POC system for the simultaneous detection of multiple viral antigens in a blood sample within 30 minutes. SERS nanotags could be useful for detecting possible infection with multiple pathogens, particularly in regions of the world, which are highly susceptible to outbreaks of infectious disease. SERS nanotags are based on a core of 60-nm AuNPs functioning as a reporter, surrounded by a silica shell. In fact, each reporter can serve as a unique fingerprint and provides identifiable J o u r n a l P r e -p r o o f SERS spectra with different antigens (Fig. 4 A, B) . SERS nanotags are stable under varying environmental conditions and do not require a cold-chain for storage and transfer, while simplifying the assay and reducing analysis time by eliminating the sample preparation and washing steps (Sebba et al., 2018) . 

SPR and LSPR systems are promising for detecting various types of clinical analytes (Masson, 2017) . In SPR, electrons are excited at the interface of a thin metal film and a dielectric medium. LSPR is an indirect approach to enhance SPR sensitivity and can be applied to label-free sensing (Malekzad et al., 2018) . Colorimetric detection using AuNPs was developed due to the effect of LSPR on the optical properties. AuNPs show a red color when they are dispersed, but when they become aggregated the color changes to blue with maximal absorbance at longer wavelength .

Colorimetric techniques based on AuNPs have been established for the rapid and simple detection of coronavirus family members in 10 min, and can entirely eliminate the need for instrumentation or skilled personnel. This nanosensor assay could accomplish the detection of MERS-CoV nucleic acids with a sensitivity limit of detection as low as 1 pmol/μL. Therefore, it could be very useful for the early diagnosis of coronavirus, which is critical for such a contagious epidemic (Kim et al., 2019) . As shown in Fig. 5A , in absence of a target, disulfide bond formation occurs between the thiolate-labeled probes. Thereafter, with the addition of salt, aggregation of Au NPs and a color change (from red to blue) can be observed along with LSPR peak changes. In the presence of a target, the thiolate probes react with the target to form a dsDNA structure, which binds to the surface of AuNPs through disulfide bonds, thus protecting the AuNPs from salt-induced aggregation and no color changes occurs ( Fig. 5B ). In fact, the very high sensitivity of AuNP-based colorimetric techniques for nucleic acid detection have stimulated the use of AuNPs for the sensitive detection of SARS-CoV-2, or in combination with other properties of AuNPs.

Cysteine and methionine binds to AuNPs through their sulfhydryl (-SH) groups and can induce the aggregation of NPs via hydrogen bond formation or zwitterionic interactions. This allows the observation of color changes (from red to blue) with the naked eyes . Since, the amino acid cysteine is present in the sequence of the antigenic proteins of SARS CoV-2, when the virus is present in the gas phase (exhaled breath, sneeze, cough) or in the solid phase (adhering to clothes, mask, or surfaces), it can be rapidly detected by using the optical properties of Au NPs. However, this method is not completely specific since cysteine amino acids may exist in other pathogen proteins, it could be useful in emergency detection leading to further RT-PCR testing. The likelihood that viruses (such as influenza and coronavirus) can be transmitted from animals to humans is an important issue. Because the transmission of viruses between different animal species and thence to humans is possible and even probable, the ability to differentiate between strains of human viruses and those of other animal species is of paramount importance in the present pandemic (Parrish et al., 2008; Bolles et al., 2011) .

Various strains of influenzas viruses can be detected using thiolate polyethylene glycol (PEG)-gold NPs (16 nm) functionalized with sialic acids containing carbohydrates (glyco-NPs). The influenza virus contains two different types of surface glycoproteins, including neuraminidase (NA) and hemagglutinin (HA). Glyco-NPs that were functionalized with trivalent α2,6-thio-linked sialic acid and mixed with human influenza virus X31 (H3N2), generated a color change that could be observed in 30 min. HA binds to the residues of α-2,6 and α-2,3 sialic acids in human and bird cells, respectively. The HA expressed by avian influenza virus binds specifically to α-2,3-sialic acid, which is preferentially expressed in the intestinal tract, while HA proteins from human-influenza viruses bind to α-2,6 sialic acid in the respiratory tract epithelial cells. As a result, based on differences in the sialic acid residues, this biosensor could distinguish between avian and human influenza viruses between 0 to 3.0 μg/mL (Marín et al., 2013) . The attachment of polyethylene glycol (PEG) chains can improve the stability of larger size AuNPs and increase the performance of nanosensors, because they prevent the nonspecific adsorption of peptides and proteins and increase the water solubility. In fact, glyco-AuNPs are a versatile hybrid nanosystem for diagnostic applications. In addition, the use of green synthesized AuNPs can effectively help to reduce the cost of the synthesis procedure, which significantly can help the early detection and treatment steps (Schulz et al., 2013; Compostella et al., 2017) .

The presence of multivalent functional groups on the surface of PEGylated NPs can play a key role in the highly selective binding to different strains of the virus. Nevertheless, heterogeneous mixtures of functional groups could increase the discriminatory ability of the biosensor (Otten et al., 2016) . For example, trivalent α2, 6-thio-linked sialic acid specifically bound to H 3 N 2 influenza virus and could distinguish between diverse strains of influenza.

Thiol-linked sialic acids in heterogeneous mixtures could also differentiate between virus strains from different animal species.

Otten et al. used heterogeneous mixtures of glycans on the surface of glyco-AuNPs to distinguish between members of a small panel of legume lectins in a green media (Otten et al., 2016) . This approach may also be used in the specific detection and differentiation between SARS-CoV and SARS-CoV-2 viruses, and different types of coronavirus from animal species. The use of PEGylated-AuNPs as a biosensor to differentiate between the two amino acids cysteine and aspartic acid was described by Chen et al. Aspartic acid was added to a solution containing NPs bound to cysteine (by SH bonds) and bound via its amine and carboxyl groups. Moreover, this study showed that increasing the size of the NPs from 13 to 45 nm could lower the detection limit (from 18 μM to 1.8 nM) .

SARS-CoV-2 virus binds to ACE2 receptors through specific amino acids in the S1 antigen protein (L455, F486, Q493, S494, N501, and Y505). Specific amino acids in human ACE2 (K31, E35, D38, M82, and K353) are able to form hydrogen bonds with the S1 protein (Luan et al., 2020; Walls et al., 2020) . Furthermore, additional binding may involve the carboxyl groups of the ACE2 receptor interacting with the carboxyl and amine groups of the S1 antigen. Based on these studies, it may be possible to specifically detect COVID-19 by designing different optical biosensors, including PEG-Au NPs, essentially based on specific binding between the amino acids (for instance D38 and S494). In addition, the use of heterogeneous mixtures of amino acids may allow better differentiation between viruses from different animal species.

The tunability of the optical-thermal properties of plasmonic AuNPs, enables plasmonic photothermal therapy (PPT), where the wavelength of the laser can be matched with the enhanced absorption in the visible and NIR spectral regions due to the SPR oscillations (Huang et al., 2007; Qiu et al., 2020 ). An optical nanosensor combining the LSPR and photothermal effect was developed to discriminate between two similar SARS-CoV-2 gene sequences with high sensitivity (detection limit of 0.22 pM). In this study, an Au film was coated with thiol-cDNA ligands and self-assembled into a nanostructured chip. In this sensor, in addition to plasmonic sensing, laser irradiation at a wavelength corresponding to the plasmonic resonance frequency led to substantial heat being generated on the AuNI chip.

This PPT heat effect raised the hybridization temperature and allowed the precise discrimination between two similar sequences. Fig. 6B shows the hybridization of a RdRp gene of SARS-CoV-2 with a complementary cDNA sequence. The photothermal effect could increase the hybridization kinetics between the two sequences, and the response-slope of J o u r n a l P r e -p r o o f LSPR with photothermal excitation was steeper than that without the photothermal excitation. Furthermore, this nanosensor was able to discriminate between two similar and noncomplementary sequences by the photothermal effect (Fig. 6C) (Qiu et al., 2020) . 

Fluorescent biosensors have high sensitivity and selectivity, and a shorter response time usage in fields such as medical diagnostics. Fluorescence biosensors use fluorescent molecules as the signal output component. The specific detection is observed through changes in the fluorescence intensity or else by creation of fluorescence polarization (Wang et al., 2011; Jeong et al., 2018) .

Quantum dots (QDs) are colloidal NPs of semiconductor origin, which have become highly popular in the nanosensing and bio-imaging fields, due to their stable optical properties, broad range excitation wavelength and tunable narrow fluorescence emission (Zhu et al., 2013) . In comparison with organic fluorophores, QDs have size-tunable optical features (e.g. emission spectrum), and by adjusting their size, coating and attached ligands, can be tailored to detect various targets with high sensitivity for different samples (Han et al., 2001) .

J o u r n a l P r e -p r o o f Ahmed et al. (2018) developed a fluorescence-based optical diagnostic nanosensor using chiral zirconium quantum dots (ZrQDs) to detect coronavirus in samples from patients with bronchitis infections. These NPs could form a strong and stable bonding with antiviral antibodies and allowed the highly sensitive detection of coronaviruses. The antibodies were conjugated with ZrQDs and magneto-plasmonic MNPs, and then after the addition of antibody-conjugated and the target virusMNPs, led to the formation of nanostructured magnetoplasmonic-fluorescent structures under the influence of an applied external magnetic field. This allowed the magnetic separation of the virus, and the photoluminescence intensity of the nanohybrids was used to measure the concentration. The low toxicity of these NPs, as well as their good binding with antiviral antibodies suggested that these NPs could be a promising nanosensor for the detection of new coronavirus species. With a diagnostic sensitivity that was 10 times higher than the ELISA technique (100 EID/50µL for NPs versus 1000 EID/50µL for ELISA), these NPs could be useful in diagnosis of pandemic viruses (Ahmed et al., 2018) .

Although antibodies are often applied in sensing assays, the sensitivity can be limited by nonspecific interactions between the antibody and the target. Antibodies are also sensitive to heat and require special reaction conditions that can limit their use (Dobson et al., 2016; Akazawa-Ogawa et al., 2018) . Aptamers are single-strand synthetic RNA, DNA, or peptide sequences that can be designed to specifically recognize targets by repeated selective enrichment procedures. Their advantages include sustainability, efficiency, and high flexibility in design, so they can be used in a wide variety of biological sensors Maghsoudi et al., 2019) . QDs could be coated with oligonucleotide aptamers (linking the aptamer amine group to the QD carboxyl group) that recognized the N protein of SARS-CoV virus. In this study, a Prolinker TM coated protein chip was used to immobilize a sample containing SARS-CoV N protein by its carboxyl groups. When the SARS N protein was present in the sample the binding of the QD-aptamer could be quantified by the fluorescent emission from the chip. The LOD was 0.1 pg/mL for this biosensor, and thus it could also be tested for detection of SARS-CoV-2 (Roh and Jo, 2011) .

Some polyphenolic compounds, such as catechin gallate and gallocatechin gallate, have shown some inhibitory potential against SARS-CoV as shown in Fig. 7A and 7B. At a concentration of 0.05 μg/mL, gallocatechin gallate and catechin gallate showed more than 40% inhibition activity as measured by a biochip system (Roh, 2012) . However, the mechanism of these compounds binding to the SARS-CoV N protein is still unclear. In this J o u r n a l P r e -p r o o f study, SARS-CoV spike proteins could be used instead of N protein, because the spike proteins are longer in length, and could provide a stronger bond by reducing the distance between the moieties .

RNA on prolinker TM -coated biochip (Roh, 2012) .

The LSPR signal from plasmonic metal NPs such as AuNPs and AgNPs has been used to amplify the fluorescence intensity signal of QDs, leading to lower detection limits (Adegoke et al., 2020) . This feature of AuNPs was used to increase the sensitivity of detection of the NS1 protein of Zika virus using a QD-labeled antibody. The AuNPs acted as a signal amplifier and the QDs acted as the fluorophore signal. When the target NS1 protein was present, the LSPR phenomenon of the AuNPs increased the intensity of the QD emission because the two particles were sufficiently close together (few nm), thus increasing the sensitivity. The results of this study showed high sensitivity and rapidity for the detection of Zika virus over a wide range of concentrations (10 fg/mL to 1 ng/mL) and a LOD of 1.28 fg/mL with 10-10(7) RNA copies/mL (Takemura et al., 2019a) . The simultaneous use of a mixture of AuNPs and AgNPs could be even more effective and reduce the LOD to 1.7 copies/mL, Nevertheless, the cost of developing a POC diagnostic platform using LSPR in low or middle-income countries may be a challenge (Adegoke et al., 2017) .

Microfluidic technology is an effective methodology in POC devices, wherein small volumes of liquid sample can circulate in micron-sized channels, allowing for the use of smaller quantities of samples and reagents. This miniaturization results in much faster detection systems than conventional techniques Jung et al., 2015) .

Microfluidic PCR chips have been developed to detect pathogens and viruses, and if properly designed, can replace conventional techniques such as RT-PCR and reduce the costs associated with diagnostics (Ahrberg et al., 2016) . Because the world has been so deeply impacted by the coronavirus, and developing countries have fewer resources, the cost of diagnosis is a significant factor to consider. When the rate of virus spread is high, the lack of cost-effective diagnostic tools can rapidly escalate the costs for health care systems.

Microfluidic chips can be constructed from different materials, such as silicon/glass, polymers such as poly-dimethyl sulfoxide (PDMS) or poly-methyl-methacrylate (PMMA), and even from paper (Kaneda et al., 2012; Nge et al., 2013; Soum et al., 2019) . Xia et al.

(2019) described a PDMS-ZnO nanorod microfluidics chip that was based on a smartphone for POC, rapid, low-cost and sensitive colorimetric detection of viruses in samples within 1.5 h (Higashi et al., 2019) . The channels of these nanostructures were made up of PDMS, and the ZnO nanorods were embedded in the channel walls, which enhanced the capture of the virus and improved the detection sensitivity. Viral specific antibodies were attached to the microchannel surface, and after the virus had bound to the antibody, a second anti-virus antibody labeled with AuNPs attached to the virus. In this system, the binding of gold acted as a signal amplifier to improve the detection limit. This system allowed rapid detection of the virus by the naked eye with a sensitivity of 2.7×10 4 EID 50/µL. This nanostructured microfluidic chip with its smartphone-enabled plasmonic detector system could be low cost, user-friendly and highly sensitive for the detection of SARS-CoV-2 virus antigenic proteins.

Chemiluminescence refers to light emission from the excited state product of a chemical reaction, when it returns to the ground state. In fact, when an electron drops to a lower energy level from a excited or higher energy level, the energy is lost in the form of light, termed a chemiluminescent reaction (Christodouleas et al., 2011) . In recent years, it has been found that chemiluminescence reactions can be catalyzed by metal NPs in immunoassays for antigen determination in assistance of using green media. This approach is not only sensitive and selective, but also simple, cost-effective and rapid (Zhou et al., 2016; Li et al., 2013) . Li J o u r n a l P r e -p r o o f et al. developed a rapid, specific and sensitive detection technique for H1N1 influenza virus based on a chemiluminescence metalloimmunoassay using AgNPs as a label, with a LOD of 0.1 pg/mL. In this system, the binding of monoclonal antibodies onto polystyrene was initially carried out by physical adsorption. When HNO 3 was added to the solution, the silver salts were released into the solution and the chemiluminescence signal was produced by the Ag + -Na 2 S 2 O 8 Mn 2+ -H 3 PO 4 luminol system .

MOFs can serve as labeling agents, due to their features such as good porosity, low toxicity, feasibility of modification on the outer surface, and pore modification through organic linkers (e.g. --COOH, -NH 2 , etc.). MOFs have a network structure with controlled chemical functionality, and the metallic centers of these particles allow their sensitive quantification by chemiluminescence approaches (Zhou et al., 2016; Miller et al., 2016) .

These properties make them ideally suited for detecting larger biomolecules, such as proteins, DNA, or RNA from pathogenic viruses. Zhou et al. (2016) reported a sensitive chemiluminescence metalloimmunoassay for the detection of alpha-fetoprotein (AFP), that used a metalloimmunoassay labelling agent such as MOF-NPs. MOF-NPs (Fe-MIL-88B-NH 2 ) was synthesized by a microwave-assisted procedure, with a size of 50 ± 5 nm in length and 30 ± 5 nm in width. The particles were bound to the secondary antibody through the carboxyl group of NH 2 -BDC and the amino group of the secondary AFP antibody. After the complete dissolution of the assay plate in hydrochloric acid and the release of Fe +3 , the signal was detected by a flow-injection luminol-H 2 O 2 chemiluminescence system (Zhou et al., 2016) (Fig. 8) . This system showed high sensitivity, low cost, good reproducibility, and was stable for long-term storage, even at room temperature. It was superior compared to systems that used other labels such as AgNPs or Fe 3 O 4 @Au (Riccò et al., 2018) . This MOF-based chemiluminescence biosensor could be used for highly sensitive and low-cost detection of COVID-19. 

In recent decades, multicomponent reactions (MCRs) have gained much attention in the synthesis of drugs, heterocyclic compounds, ligands and biologically active molecules. In addition, this approach can effectively help the green chemistry and sustainable rules (Graebin et al., 2019; Shaabani and Hooshmand, 2018) . MCRs have recently been applied to prepare functionalized nanomaterials, which are used as biosensors, nanocarriers for drug delivery, bioimaging reporters, antibacterial materials and so on (Afshari and Shaabani, 2018) . MCRs are single-step and one-pot reactions (most of them recently focused on green synthesized approaches by using water as the solvent) that include three or more commercially available or easily accessible starting materials, and which allow the Camacho and co-workers devised an innovative synthetic strategy for the construction of an alginate modified-gold electrode for immobilizing horseradish peroxidase (HRP) enzyme using an Ugi four-component reaction (Camacho et al., 2007) . In this procedure, the alginatecoated Au electrode was modified using the Ugi MCR method to produce a support for immobilizing the enzyme. Ultimately, the enzyme-modified Au electrode was a highly sensitive and rapid electroanalytical biosensor for detection of H 2 O 2 . Another approach for the construction of biosensors based on the MCR strategy was developed by Vrbova and

Marek, who used collagen as a natural material to fabricate an enzyme-catalyzed electrode for D-galactose determination. They immobilized galactose oxidase or co-immobilized galactose oxidase plus catalase to a Clark-type oxygen sensor using the Ugi-four component MCR (Vrbová and Marek, 1990) . In this approach, the prepared biosensor was investigated for the detection of D-galactose in real samples of plasma and serum from patients with J o u r n a l P r e -p r o o f suspected galactosemia. In 2018, Lowe et al. described an efficient route for the development of a holographic sensor modified with Ugi-4MCR ligands for cocaine determination using a smart-phone based device (Oliveira et al., 2018) . Several ligands were prepared to perform protein−cocaine binding, especially human carboxylesterase-1 and the catalytic monoclonal antibody GNL7A1. The Ugi-4CR reaction involved β-alanine, γ-aminobutyric acid, and cyclohexyl isocyanide below the surface of a hybrid hydrogel of poly(2-hydroxyethylmethacrylate−co-ethylene dimethacrylate-co-methacrolein) as the carbonyl source. The efficiency of the MCR platform for the rapid detection of cocaine in the same range as clinical drug samples was demonstrated. (Figure 10 ) Figure 10 . Development of Ugi-holographic biosensor for cocaine detection applying a smartphone-based device. Reproduced with permission from ref. (Oliveira et al., 2018) .

Copyright (2018) Elsevier.

Based on the above-mentioned data, MCRs could be used as versatile and flexible synthetic tools to design an effective biosensor for the rapid detection of COVID-19. On account of the fact that MCRs are able to incorporate several different bioreceptors within a single platform, this approach could produce a highly sensitive and rapid optical biosensor.

J o u r n a l P r e -p r o o f

In recent years, various computational approaches have been employed in drug discovery and biosensor development. These encompass QSAR, virtual screening, molecular docking, homology modelling, and machine learning approaches (Gonzalez-Navarro et al., 2016; Green et al., 2019) . Some of these methods have their own advantages and drawbacks.

Docking simulations can pinpoint and optimize the 3D structure of small molecules as well as identify potential binding sites. However, the docking simulation process is somewhat tedious, particularly for macromolecular compounds (Bagherian et al., 2020) . Methods which employ data from more computationally rigorous, and physically accurate calculations, such as molecular dynamics simulations (MD), are limited in applicability due to their computational cost and poor accuracy (Ellingson et al., 2020) . Machine learning techniques have revolutionized the use of computational methods in systems biology. Machine learning can accurately analyze the correlation between chemical structure and interactions with known proteins to form ligand pairs, to provide statistical models to predict the activity of other unknown compounds. The prediction of binding energy requires a regression algorithm, and predicting the likelihood of an interaction could be achieved (Kundu et al., 2018) . In addition, a statistical learning approach has very recently been applied for the classification of G-protein coupled receptors and DNA-binding proteins. This approach has been used with several protein structures to predict interactions, including protein-protein interactions (Bock and Gough, 2001) , fold recognition (Dubchak et al., 1995) , and also structural predictions (Cai et al., 2002) .

In order to discover new bioreceptors which might bind to specific targets in the COVID-19

virus, a machine learning approach could provide a more reliable and rapid solution.

The rapid and sensitive detection of pandemic COVID-19 virus, could be the key to limit the transmission throughout the world. Various diagnostic techniques have already been developed for detecting COVID-19, and some have even been commercialized. However, the most important point to consider for diagnosis in different countries, is to develop techniques that are inexpensive, simple and user-friendly. It is important to reduce the cost of diagnosis to produce the best result in the shortest possible time, as well as to reduce the need to travel hospitals or clinics by developing POC systems. One important example that has not so far received much attention, concerns the plasmonic and optical properties of nanomaterials, such as AuNPs which could be incorporated into face-masks or PPE in the form of J o u r n a l P r e -p r o o f nanotechnology-enabled functional clothing. In the presence of SARS-CoV-2, the color of the NPs could significantly change, to allow quick and easy virus detection and prevent the further spread of the virus.

Given the widespread prevalence of COVID-19 worldwide and the increasing mortality, early and highly accurate detection of suspected or infected individuals can play an important role in reducing mortality and preventing other people from becoming infected. Various studies by researchers around the world have led to the development of diagnostic systems based on optical nanosensors, with an emphasis on the development of POC devices. New creative ideas can lead to more innovative approaches, which could significantly reduce the prevalence and mortality of this pandemic disease. The other authors declare there are no conflicts of interests.

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

Localized surface plasmon resonance-mediated fluorescence signals in plasmonic nanoparticle-quantum dot hybrids for ultrasensitive Zika virus RNA detection via hairpin hybridization assays

Aptamerbased cocaine assay using a nanohybrid composed of ZnS/Ag2Se quantum dots, graphene oxide and gold nanoparticles as a fluorescent probe

Materials Functionalization with Multicomponent Reactions: State of the Art

Thiol-Capped Gold Nanoparticle Biosensors for Rapid and Sensitive Visual Colorimetric Detection of Klebsiella pneumoniae

Application of Aptamer-based Hybrid Molecules in Early Diagnosis and Treatment of Diabetes Mellitus: From the Concepts Towards the Future

Chiral zirconium quantum dots: A new class of nanocrystals for optical detection of coronavirus

Polymerase chain reaction in microfluidic devices

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease

Heat denaturation of the antibody, a multidomain protein

What do we know about multicomponent reactions? Mechanisms and trends for the Biginelli

A serological assay to detect SARS-CoV-2 seroconversion in humans

The proximal origin of SARS-CoV-2

Detection of norovirus virus-like particles using a surface plasmon resonanceassisted fluoroimmunosensor optimized for quantum dot fluorescent labels

Machine learning approaches and databases for prediction of drug-target interaction: a survey paper

A SPR Aptasensor for detection of avian influenza virus H5N1

HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform

Predicting protein-protein interactions from primary structure

SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission

CRISPR-Cas12-based detection of SARS-CoV-2

Prediction of protein structural classes by support vector machines

Amperometric enzyme biosensor for hydrogen peroxide via Ugi multicomponent reaction

Zika Immunoassay Based on Surface-Enhanced Raman Scattering Nanoprobes

Assay Techniques and Test Development for COVID-19 Diagnosis

Direct colorimetric detection of aspartic acid in rat brain based on oriented aggregation of

Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2

Flow-Based Methods with Chemiluminescence Detection for Food and Environmental Analysis: A Review

Novel Coronavirus (COVID-19) Pneumonia

Glyco-gold nanoparticles: synthesis and applications

Engineering the surface properties of a human monoclonal antibody prevents selfassociation and rapid clearance in vivo

Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity

Prediction of protein folding class using global description of amino acid sequence

Machine learning and ligand binding predictions: A review of data, methods, and obstacles

Sensitivity of chest CT for COVID-19: comparison to RT-PCR

Evaluation of seven commercial RT-PCR kits for COVID-19 testing in pooled clinical specimens

Glucose Oxidase Biosensor Modeling and Predictors Optimization by

Multicomponent Reactions for the Synthesis of Bioactive Compounds: A Review

Prospects for point-of-care pathogen diagnostics using surface-enhanced Raman scattering (SERS)

Machine learning detection of obstructive hypertrophic cardiomyopathy using a wearable biosensor

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status

Development of gold nanoparticles biosensor for ultrasensitive diagnosis of foot and mouth disease virus

Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules

One-pot synthesis of cyclodextrin-based radial poly [n] catenanes

Plasmonic photothermal therapy (PPTT) using gold nanoparticles

Metal enhanced fluorescence (MEF) for biosensors: General approaches and a review of recent developments

Point-of-care testing for COVID-19 using SHERLOCK diagnostics. medRxiv : the preprint server for health sciences

Point-of-care testing (POCT) diagnostic systems using microfluidic lab-on-a-chip technologies

Modification of the Glass Surface Property in PDMS-Glass Hybrid Microfluidic Devices

Electrochemical virus detections with nanobiosensors

Comparative Evaluation of the LAMP Assay and PCR-Based Assays for the Rapid Detection of Alternaria solani

Development of Label-Free Colorimetric Assay for MERS-CoV Using Gold Nanoparticles

Point-of-Care Testing for Infectious Diseases: Past, Present, and Future

A novel coronavirus associated with severe acute respiratory syndrome

A machine learning approach towards the prediction of protein-ligand binding affinity based on fundamental molecular properties

Metal-organic frameworks: opportunities and challenges for surface-enhanced Raman scattering -a review

Multiplex in vitro detection using SERS

Evaluation of nine commercial SARS-CoV-2 immunoassays

Plasmonic Nanomaterial-Based Optical Biosensing Platforms for Virus Detection

Respiratory virus shedding in exhaled breath and efficacy of face masks

Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

Molecular immune pathogenesis and diagnosis of COVID-19

A highly sensitive chemiluminescent metalloimmunoassay for H1N1 influenza virus detection based on a silver nanoparticle label

Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection

Recent Advancements in aptamer-bioconjugates: Sharpening Stones for breast and prostate cancers targeting

Noble metal nanostructures in optical biosensors: Basics, and their introduction to anti-doping detection

Glyconanoparticles for the plasmonic detection and discrimination between human and avian influenza virus

Surface Plasmon Resonance Clinical Biosensors for Medical Diagnostics

The new age of MOFs and of their porous-related solids

Metal-organic frameworks as biosensors for luminescence-based detection and imaging

A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry

Review of SERS Substrates for Chemical Sensing

Accelerated reaction by loop-mediated isothermal amplification using loop primers

Point-of-care microfluidic devices for pathogen detection

Advances in Microfluidic Materials, Functions, Integration, and Applications

Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics

Application of nanomaterials in treatment, anti-infection and detection of coronaviruses

A holographic sensor based on a biomimetic affinity ligand for the detection of cocaine

Glycan heterogeneity on gold nanoparticles increases lectin discrimination capacity in label-free multiplexed bioassays

Optical Diagnostic Based on Functionalized Gold Nanoparticles

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

A fluorescent aptasensor for H5N1 influenza virus detection based-on the core-shell nanoparticles metal-enhanced fluorescence (MEF)

Cross-species virus transmission and the emergence of new epidemic diseases

Recent Progress in Optical Sensors for Biomedical Diagnostics

Rapid detection and quantification of Enterovirus 71 by a portable surface plasmon resonance biosensor

Selective Surface Enhanced Raman Scattering for Quantitative Detection of Lung Cancer Biomarkers in Superparticle@MOF Structure

Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study. medRxiv : the preprint server for health sciences

Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection

Nanomaterial-based devices for point-of-care diagnostic applications

One-pot synthesis of hetero [6] rotaxane bearing three different kinds of macrocycle through a selfsorting process

Metal-Organic Frameworks for Cell and Virus Biology: A Perspective

A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide

Quantitative and sensitive detection of SARS coronavirus nucleocapsid protein using quantum dots-conjugated RNA aptamer on chip

Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites

Effect of the Spacer Structure on the Stability of Gold Nanoparticles Functionalized with Monodentate Thiolated Poly(ethylene glycol) Ligands

A point-of-care diagnostic for differentiating Ebola from endemic febrile diseases

Diversity-oriented catalyst-free synthesis of pseudopeptides containing rhodanine scaffolds via a one-pot sequential isocyanide-based six-component reactions in water using ultrasound irradiation

From SARS to MERS, Thrusting Coronaviruses into the Spotlight

High-throughput sequencing for biology and medicine

Programmable Paper-Based Microfluidic Devices for Biomarker Detections

Localized surface plasmon resonance based point-of-care system for sepsis diagnosis

A localized surface plasmon resonanceamplified immunofluorescence biosensor for ultrasensitive and rapid detection of nonstructural protein 1 of Zika virus

Ultrasensitive detection of norovirus using a magnetofluoroimmunoassay based on synergic properties of gold/magnetic nanoparticle hybrid nanocomposites and quantum dots

Wide dynamic range of surface-plasmonresonance-based assay for Hepatitis-B-surface-antigen-antibody optimal detection in comparison with ELISA

Advances in Plasmonic Technologies for Point of Care Applications

Development of a Gold Nanoparticle-Based Lateral-Flow Immunoassay for Pneumocystis Pneumonia Serological Diagnosis at Point-of-Care

Diagnosing COVID-19: The Disease and Tools for Detection

Incorporation of Spike and Membrane Glycoproteins into Coronavirus Virions

Comparison of seven commercial RT-PCR diagnostic kits for COVID-19

Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends. Diagnostics 10

Real-time Detection and Monitoring of Loop Mediated Amplifcation (LAMP) Reaction Using Self-quenching and Dequenching Fluorogenic Probes

Application of the Ugi reaction for the preparation of enzyme electrodes

2020. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell

Viruses in bats and potential spillover to animals and humans

Aptamer-based fluorescent biosensors

Limits of Detection of 6 Approved RT-PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2)

Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR. medRxiv

Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing

Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay

The Ugi reaction in polymer chemistry: syntheses, applications and perspectives

COVID-19: a new challenge for human beings

SERS detection of hepatitis B virus DNA in a temperatureresponsive sandwich-hybridization assay

A protocol for detection of COVID-19 using CRISPR diagnostics

Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP

A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2. bioRxiv

A chemiluminescence metalloimmunoassay for sensitive detection of alpha-fetoprotein in human serum using Fe-MIL-88B-NH2 as a label

A Novel Coronavirus from Patients with Pneumonia in China

Quantum dot-based nanoprobes for in vivo targeted imaging

The financial support of the